ベラパミル市場:世界の見通し・予測2021-2027

◆英語タイトル:Verapamil Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21JY2196
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年6月
◆ページ数:94
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥357,500見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥464,750見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥536,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Market Monitor Global社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Market Monitor Global社が発行した本調査レポートは、世界のベラパミル市場について調査し取りまとめました。ベラパミルの世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(錠剤、カプセル、注射、その他)、用途別分析(病院薬局、小売薬局、オンライン販売、その他)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界のベラパミル市場規模2021年vs2027年
・世界のベラパミル市場:売上予測2016年-2027年
・主要企業別のベラパミル売上・市場シェア・価格
・ベラパミルの種類別市場規模:錠剤、カプセル、注射、その他
・ベラパミルの用途別市場規模:病院薬局、小売薬局、オンライン販売、その他
・地域別市場規模
・ベラパミルの北米市場:アメリカ市場、カナダ市場、メキシコ市場
・ベラパミルのヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・ベラパミルのアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・ベラパミルの南米市場:ブラジル市場、アルゼンチン市場など
・ベラパミルの中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:REPLEK FARM、 Mylan、 Abbott Laboratories、 YUNGSHIN PHARM IND. CO. LTD、 The Central Pharmaceutical CO.,Ltd.Tianjin
・世界のベラパミルの生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・ベラパミルのサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of Verapamil in global, including the following market information:
Global Verapamil Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Verapamil Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Verapamil companies in 2020 (%)
The global Verapamil market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Verapamil manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Verapamil Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Verapamil Market Segment Percentages, By Type, 2020 (%)
Tablets
Capsules
Injection
Others

Global Verapamil Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Verapamil Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others

Global Verapamil Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Verapamil Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Verapamil revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Verapamil revenues share in global market, 2020 (%)
Key companies Verapamil sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Verapamil sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
REPLEK FARM
Mylan
Abbott Laboratories
YUNGSHIN PHARM IND. CO. LTD
The Central Pharmaceutical CO.,Ltd.Tianjin

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 Verapamil Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Verapamil Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Verapamil Overall Market Size
2.1 Global Verapamil Market Size: 2021 VS 2027
2.2 Global Verapamil Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Verapamil Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Verapamil Players in Global Market
3.2 Top Global Verapamil Companies Ranked by Revenue
3.3 Global Verapamil Revenue by Companies
3.4 Global Verapamil Sales by Companies
3.5 Global Verapamil Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Verapamil Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Verapamil Product Type
3.8 Tier 1, Tier 2 and Tier 3 Verapamil Players in Global Market
3.8.1 List of Global Tier 1 Verapamil Companies
3.8.2 List of Global Tier 2 and Tier 3 Verapamil Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Verapamil Market Size Markets, 2021 & 2027
4.1.2 Tablets
4.1.3 Capsules
4.1.4 Injection
4.1.5 Others
4.2 By Type – Global Verapamil Revenue & Forecasts
4.2.1 By Type – Global Verapamil Revenue, 2016-2021
4.2.2 By Type – Global Verapamil Revenue, 2022-2027
4.2.3 By Type – Global Verapamil Revenue Market Share, 2016-2027
4.3 By Type – Global Verapamil Sales & Forecasts
4.3.1 By Type – Global Verapamil Sales, 2016-2021
4.3.2 By Type – Global Verapamil Sales, 2022-2027
4.3.3 By Type – Global Verapamil Sales Market Share, 2016-2027
4.4 By Type – Global Verapamil Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Verapamil Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Sales
5.1.5 Others
5.2 By Application – Global Verapamil Revenue & Forecasts
5.2.1 By Application – Global Verapamil Revenue, 2016-2021
5.2.2 By Application – Global Verapamil Revenue, 2022-2027
5.2.3 By Application – Global Verapamil Revenue Market Share, 2016-2027
5.3 By Application – Global Verapamil Sales & Forecasts
5.3.1 By Application – Global Verapamil Sales, 2016-2021
5.3.2 By Application – Global Verapamil Sales, 2022-2027
5.3.3 By Application – Global Verapamil Sales Market Share, 2016-2027
5.4 By Application – Global Verapamil Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Verapamil Market Size, 2021 & 2027
6.2 By Region – Global Verapamil Revenue & Forecasts
6.2.1 By Region – Global Verapamil Revenue, 2016-2021
6.2.2 By Region – Global Verapamil Revenue, 2022-2027
6.2.3 By Region – Global Verapamil Revenue Market Share, 2016-2027
6.3 By Region – Global Verapamil Sales & Forecasts
6.3.1 By Region – Global Verapamil Sales, 2016-2021
6.3.2 By Region – Global Verapamil Sales, 2022-2027
6.3.3 By Region – Global Verapamil Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Verapamil Revenue, 2016-2027
6.4.2 By Country – North America Verapamil Sales, 2016-2027
6.4.3 US Verapamil Market Size, 2016-2027
6.4.4 Canada Verapamil Market Size, 2016-2027
6.4.5 Mexico Verapamil Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Verapamil Revenue, 2016-2027
6.5.2 By Country – Europe Verapamil Sales, 2016-2027
6.5.3 Germany Verapamil Market Size, 2016-2027
6.5.4 France Verapamil Market Size, 2016-2027
6.5.5 U.K. Verapamil Market Size, 2016-2027
6.5.6 Italy Verapamil Market Size, 2016-2027
6.5.7 Russia Verapamil Market Size, 2016-2027
6.5.8 Nordic Countries Verapamil Market Size, 2016-2027
6.5.9 Benelux Verapamil Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Verapamil Revenue, 2016-2027
6.6.2 By Region – Asia Verapamil Sales, 2016-2027
6.6.3 China Verapamil Market Size, 2016-2027
6.6.4 Japan Verapamil Market Size, 2016-2027
6.6.5 South Korea Verapamil Market Size, 2016-2027
6.6.6 Southeast Asia Verapamil Market Size, 2016-2027
6.6.7 India Verapamil Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Verapamil Revenue, 2016-2027
6.7.2 By Country – South America Verapamil Sales, 2016-2027
6.7.3 Brazil Verapamil Market Size, 2016-2027
6.7.4 Argentina Verapamil Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Verapamil Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Verapamil Sales, 2016-2027
6.8.3 Turkey Verapamil Market Size, 2016-2027
6.8.4 Israel Verapamil Market Size, 2016-2027
6.8.5 Saudi Arabia Verapamil Market Size, 2016-2027
6.8.6 UAE Verapamil Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 REPLEK FARM
7.1.1 REPLEK FARM Corporate Summary
7.1.2 REPLEK FARM Business Overview
7.1.3 REPLEK FARM Verapamil Major Product Offerings
7.1.4 REPLEK FARM Verapamil Sales and Revenue in Global (2016-2021)
7.1.5 REPLEK FARM Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Verapamil Major Product Offerings
7.2.4 Mylan Verapamil Sales and Revenue in Global (2016-2021)
7.2.5 Mylan Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Verapamil Major Product Offerings
7.3.4 Abbott Laboratories Verapamil Sales and Revenue in Global (2016-2021)
7.3.5 Abbott Laboratories Key News
7.4 YUNGSHIN PHARM IND. CO. LTD
7.4.1 YUNGSHIN PHARM IND. CO. LTD Corporate Summary
7.4.2 YUNGSHIN PHARM IND. CO. LTD Business Overview
7.4.3 YUNGSHIN PHARM IND. CO. LTD Verapamil Major Product Offerings
7.4.4 YUNGSHIN PHARM IND. CO. LTD Verapamil Sales and Revenue in Global (2016-2021)
7.4.5 YUNGSHIN PHARM IND. CO. LTD Key News
7.5 The Central Pharmaceutical CO.,Ltd.Tianjin
7.5.1 The Central Pharmaceutical CO.,Ltd.Tianjin Corporate Summary
7.5.2 The Central Pharmaceutical CO.,Ltd.Tianjin Business Overview
7.5.3 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Major Product Offerings
7.5.4 The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales and Revenue in Global (2016-2021)
7.5.5 The Central Pharmaceutical CO.,Ltd.Tianjin Key News
8 Global Verapamil Production Capacity, Analysis
8.1 Global Verapamil Production Capacity, 2016-2027
8.2 Verapamil Production Capacity of Key Manufacturers in Global Market
8.3 Global Verapamil Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Verapamil Supply Chain Analysis
10.1 Verapamil Industry Value Chain
10.2 Verapamil Upstream Market
10.3 Verapamil Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Verapamil Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Verapamil in Global Market
Table 2. Top Verapamil Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Verapamil Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Verapamil Revenue Share by Companies, 2016-2021
Table 5. Global Verapamil Sales by Companies, (K Units), 2016-2021
Table 6. Global Verapamil Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Verapamil Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Verapamil Product Type
Table 9. List of Global Tier 1 Verapamil Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Verapamil Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Verapamil Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Verapamil Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Verapamil Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Verapamil Sales (K Units), 2016-2021
Table 15. By Type - Global Verapamil Sales (K Units), 2022-2027
Table 16. By Application – Global Verapamil Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Verapamil Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Verapamil Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Verapamil Sales (K Units), 2016-2021
Table 20. By Application - Global Verapamil Sales (K Units), 2022-2027
Table 21. By Region – Global Verapamil Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Verapamil Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Verapamil Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Verapamil Sales (K Units), 2016-2021
Table 25. By Region - Global Verapamil Sales (K Units), 2022-2027
Table 26. By Country - North America Verapamil Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Verapamil Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Verapamil Sales, (K Units), 2016-2021
Table 29. By Country - North America Verapamil Sales, (K Units), 2022-2027
Table 30. By Country - Europe Verapamil Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Verapamil Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Verapamil Sales, (K Units), 2016-2021
Table 33. By Country - Europe Verapamil Sales, (K Units), 2022-2027
Table 34. By Region - Asia Verapamil Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Verapamil Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Verapamil Sales, (K Units), 2016-2021
Table 37. By Region - Asia Verapamil Sales, (K Units), 2022-2027
Table 38. By Country - South America Verapamil Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Verapamil Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Verapamil Sales, (K Units), 2016-2021
Table 41. By Country - South America Verapamil Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Verapamil Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Verapamil Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Verapamil Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Verapamil Sales, (K Units), 2022-2027
Table 46. REPLEK FARM Corporate Summary
Table 47. REPLEK FARM Verapamil Product Offerings
Table 48. REPLEK FARM Verapamil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Mylan Corporate Summary
Table 50. Mylan Verapamil Product Offerings
Table 51. Mylan Verapamil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Abbott Laboratories Corporate Summary
Table 53. Abbott Laboratories Verapamil Product Offerings
Table 54. Abbott Laboratories Verapamil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. YUNGSHIN PHARM IND. CO. LTD Corporate Summary
Table 56. YUNGSHIN PHARM IND. CO. LTD Verapamil Product Offerings
Table 57. YUNGSHIN PHARM IND. CO. LTD Verapamil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. The Central Pharmaceutical CO.,Ltd.Tianjin Corporate Summary
Table 59. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Offerings
Table 60. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Verapamil Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 62. Global Verapamil Capacity Market Share of Key Manufacturers, 2019-2021
Table 63. Global Verapamil Production by Region, 2016-2021 (K Units)
Table 64. Global Verapamil Production by Region, 2022-2027 (K Units)
Table 65. Verapamil Market Opportunities & Trends in Global Market
Table 66. Verapamil Market Drivers in Global Market
Table 67. Verapamil Market Restraints in Global Market
Table 68. Verapamil Raw Materials
Table 69. Verapamil Raw Materials Suppliers in Global Market
Table 70. Typical Verapamil Downstream
Table 71. Verapamil Downstream Clients in Global Market
Table 72. Verapamil Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Verapamil Segment by Type
Figure 2. Verapamil Segment by Application
Figure 3. Global Verapamil Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Verapamil Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Verapamil Revenue, 2016-2027 (US$, Mn)
Figure 7. Verapamil Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Verapamil Revenue in 2020
Figure 9. By Type - Global Verapamil Sales Market Share, 2016-2027
Figure 10. By Type - Global Verapamil Revenue Market Share, 2016-2027
Figure 11. By Type - Global Verapamil Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Verapamil Sales Market Share, 2016-2027
Figure 13. By Application - Global Verapamil Revenue Market Share, 2016-2027
Figure 14. By Application - Global Verapamil Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Verapamil Sales Market Share, 2016-2027
Figure 16. By Region - Global Verapamil Revenue Market Share, 2016-2027
Figure 17. By Country - North America Verapamil Revenue Market Share, 2016-2027
Figure 18. By Country - North America Verapamil Sales Market Share, 2016-2027
Figure 19. US Verapamil Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Verapamil Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Verapamil Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Verapamil Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Verapamil Sales Market Share, 2016-2027
Figure 24. Germany Verapamil Revenue, (US$, Mn), 2016-2027
Figure 25. France Verapamil Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Verapamil Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Verapamil Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Verapamil Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Verapamil Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Verapamil Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Verapamil Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Verapamil Sales Market Share, 2016-2027
Figure 33. China Verapamil Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Verapamil Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Verapamil Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Verapamil Revenue, (US$, Mn), 2016-2027
Figure 37. India Verapamil Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Verapamil Revenue Market Share, 2016-2027
Figure 39. By Country - South America Verapamil Sales Market Share, 2016-2027
Figure 40. Brazil Verapamil Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Verapamil Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Verapamil Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Verapamil Sales Market Share, 2016-2027
Figure 44. Turkey Verapamil Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Verapamil Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Verapamil Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Verapamil Revenue, (US$, Mn), 2016-2027
Figure 48. Global Verapamil Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Verapamil by Region, 2020 VS 2027
Figure 50. Verapamil Industry Value Chain
Figure 51. Marketing Channels


【掲載企業】

REPLEK FARM、 Mylan、 Abbott Laboratories、 YUNGSHIN PHARM IND. CO. LTD、 The Central Pharmaceutical CO.,Ltd.Tianjin

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ベラパミル市場:世界の見通し・予測2021-2027]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆